Cardiff Oncology
CRDF • NASDAQ
Cardiff Oncology is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Mani Mohindru, with a market cap of $114.2M.
Market Cap$114.2M
Employees32.0
CEOMani Mohindru
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
Cardiff Oncology FAQ
Common questions about Cardiff Oncology
Cardiff Oncology is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $102.5K.
Cardiff Oncology has approximately 32 employees.